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Abstract
Objectives:  Set  the sensitivity  of  the  histopathological  diagnosis  of  chorioamnionitis  (CAMH)  for
early diagnosis  of neonatal  sepsis  and  the  relationship  between  histological  chorioamnionitis
and premature  rupture  of  membranes  and  neonatal  sepsis.
Materials and  methods:  Prospective,  observational  study  and  diagnostic  test  performed  in  the
Neonatology  Service  of  the  ‘‘Dr.  José  Eleuterio  González’’  University  Hospital.  Epidemiological
variables were  collected  from  mothers  and  newborns.  The  relationship  between  histological
chorioamnionitis  with  premature  rupture  of membranes  and early  neonatal  sepsis  was  estab-
lished.
Results: We  recorded  3694  births.  Of  these,  122 patients  were  studied  as  potentially  infected,
of whom  37  patients  were  excluded  (2 by  transfer  to  another  hospital  and  35  by  not  finding  a
histopathological  study  of  the  placenta).  The  study  included  85  newborns.  Of  these,  43  (50.5%)
developed  clinical  and laboratory  data  of  early  neonatal  sepsis,  the  rest  (n  = 42,  49.5%)  were
healthy newborns.  The  sensitivity  of  histological  chorioamnionitis  with  premature  rupture  of
membranes  (PRM)  of  more  than  24  h was  81%  for  neonatal  sepsis  and  51%  without.  The  risk
factors  for  neonatal  sepsis  were:  Mother  with  infection  (p  <  0.001),  weight  <1500  g (<0.001),
gestational  age <28  weeks  (<0.05),  APGAR  score  <6  in  5 min  (p  <  0.05).
Conclusions:  Placental  chorioamnionitis  with  premature  rupture  of  membranes  >  24  h has  an
81% sensitivity  for  neonatal  sepsis.  A newborn  with  histological  chorioamnionitis  has  a  51%
sensitivity  for  neonatal  sepsis.
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Introduction
Chorioamnionitis  (CAM)  is  the  inflammation  of  the  amnio-
chorionic  membrane  and the most  frequent  cause of
premature  delivery.  Chorioamnionitis  can  be  clinically
defined  based  on  maternal  symptoms  which  include  fever,
abdominal  pain,  abnormal  vaginal  flow  and  leukocytosis.  It
can  also  be  histologically  defined  with  evidence  of  inflam-
mation  and  necrosis  in the entire chorionic  plate  and
amnion.  Chorioamnionitis  is  linked  to  significant  maternal
and  neonatal  morbidity  and  mortality  rates.1--11 It  often
occurs  through  an ascending  and  multi-bacterial  infection.
CAM  can  cause  fetal  inflammatory  response  syndrome,  which
brings  along  greater  risks of  periventricular  leukomalacia
(PVL),  cerebral  palsy  and chronic  pulmonary  disease.12--15
The  objective  of this  study  was  to  correlate  histological
chorioamnionitis  sensitivity  with  neonatal  sepsis  and  pre-
mature  rupture  of  membranes  (PRM).
Materials and  methods
An  observational,  prospective  study  and  a  diagnostic  test
were  conducted  at the neonatal  service  of  the  ‘‘Dr.  Jose  E.
Gonzalez’’  University  Hospital  of  the  Autonomous  University
of  Nuevo  León,  from  August  1st,  2012  to  July  31st,  2013.  This
study  was accepted  by the institution’s  Ethics  Committee
with  the  folio  no.  NE12-002.
The study  included  those  patients  admitted  to the  Neona-
tal  Intermediate  and  Intensive  Care  Units  with  a diagnosis
of  potentially  infected,  with  a  history  of  premature  rup-
ture  of  membranes  with  18  h  of  evolution  or  longer,  maternal
fever,  warm  and/or  fetid  uterine  cavity,  and  a  histopatholog-
ical  study  of the  placenta.  On  the other  hand,  we  excluded
potentially  infected  newborns  born  in a  different  hospi-
tal  and,  lastly,  we  eliminated  patients  who  did  not have a
histopathological  study  of  the  placenta.
The sample  was  made  by  convenience  and included  the
potentially  infected  patients.  After  looking  at in-hospital
clinical  evolution  the patients  were  divided  into  two  groups
for  analytical  comparison:  the  first  group  included  patients
with  neonatal  sepsis  and  the  second  group  was  a control
group  which  included  healthy  patients.
Studied  variables
Maternal  history
Maternal  age,  divided  into,  <18 years  old,  19--30  years  old
and  >30  years  old; health,  subdivided  into  healthy  moth-
ers  and  history  of threatened  abortion,  premature  delivery,
infections,  preeclampsia,  eclampsia,  gestational  diabetes,
chorioamnionitis,  antepartum  hemorrhages  and premature
rupture  of membranes,  with  a  subdivision  of time  intervals
of:  18--24  h,  25--48 h, 49--72  h  and  >72  h.
Variables  of  newborns
Weight  at  birth  in  grams,  divided  into  <1000,  1000--1500,
1501--2500,  2501--4000  and >4000;  gestational  age  in weeks
according  to  the  following  intervals:  <28  weeks,  28--33
weeks,  34--36  weeks,  37--42  and >42 weeks.  Trophism
according  to a percentile  in  weight  divided  into;  adequate
for  gestational  age,  small  for  gestational  age  and  large  for
gestational  age;  male  or  female,  and  APGAR  score  at 5 min
divided  as  follows:  0--3 points,  4--6  points  and  7--10 points.
Qualitative  variables  were  used  in  the  statistical  anal-
ysis.  Hypothesis  tests  were  the following:  chi  square  test
(non-parametric),  an  alpha  value  of  0.05  was  used  and  the
null  hypothesis  was  rejected  when the critical  value  was  less
than  0.05.  For  those  variables  representing  statistically  sig-
nificant  numbers,  the odds  ratios  were  obtained,  and  when
they  were  based  on  a confidence  interval  of  95%,  risk  factors
supporting  the alternative  hypothesis  and  protective  factors
were  obtained.  Sensitivity  and  specificity  were  obtained,  as
well  as  positive  and negative  predictive  values  using a  2 ×  2
contingency  table where  the  predictive  or  ‘‘independent’’
variable  was  the premature  rupture  of membranes  and  the
outcome  or  ‘‘dependent’’  variable  was  neonatal  sepsis.
Sensitivity  and  specificity  were  obtained,  as  well  as  pos-
itive  and  negative  predictive  values  using  chorioamnionitis
with  sepsis  as  a  predictive  variable  and  the  ruptured  sac
>24  h as  another  dependent  variable.
Results
There  were  3694  births  in  the  studied  period.  Of  these,  122
patients  were  studied  as  potentially  infected.  37  patients
were  excluded  (2 because  they  were  moved  to  a different
hospital  and  35  because  they  did not  have  the histopatholog-
ical study  of the placenta).  In the end,  the  studied  sample
was  85  newborns.  Out  of these,  50.5%  (n =  43)  developed
clinical  and  laboratory  data  of  early  neonatal  sepsis,  the
rest  49.5%  (n  =  42)  were  reported  as  healthy.
When  comparing  maternal  history  in both  groups  (neona-
tal  sepsis  vs.  healthy)  the findings  were  the following:
maternal  age  of  the study  groups was  the same,  with  the
highest  number  of  mothers  in  the  19--35  years  old  group.
Regarding  maternal  health  during  pregnancy,  mothers  of
the  neonatal  sepsis  group  had a higher  morbidity  p < 0.001,
among  which  infections  standout  (23%  vs. 4.7%)  p < 0.05.  The
rest  of  the  diseases  registered  without  a significant  number.
Regarding  ruptured  sac  time,  in both  groups,  the  highest
percentage  was  found  in rupture  over  72  h,  in the statistical
analysis,  both  groups  were the same.  In  prenatal  care,  both
groups  were  similar,  with  86%  of  the patients  in the neonatal
sepsis  group  and  90.4%  in the healthy  group  (Table  1).
Newborns’  characteristics
When  comparing  weight  at birth,  most  patients  with  sep-
sis weighed  under 2500  g (<0.05).  Regarding  age groups,
the  <28  weeks  group  had 20.9%  of  newborns  with  sepsis
and 2.3%  of the healthy  ones  (p  < 0.01). We  identified  the
largest  group  in  the  28--33  weeks  interval,  with  51.1%  of
the  patients  with  sepsis  and  30.9%  of  the healthy  ones,  a
non-significant  number  compared  with  the group  of  34--36
weeks  with  9.3%  septic  patients  and  45.2%  healthy  ones
(p  <  0.001);  gestational  ages  of  37--42 and  more  weeks  were
without  significant  numbers.  Regarding  trophism,  the  largest
number  corresponded  to  an adequate  weight  for  gestational
age  in  both  groups  (62.7%  and  76.1%,  septic  and healthy
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Table  1  Maternal  antecedents.
Neonatal  sepsis
n = 43  (%)
Healthy
n  =  42  (%)
p
Maternal  age
<18  years  8 (18.6)  7 (16.6)  0.813
19--35 years  30  (69.7)  24  (57.1)  0.226
>35 years  5 (11.6)  11  (26.1)  0.085
Maternal health  during  pregnancy
Healthy 26  (60.4)  36  (85.7)  <0.01
Threat of  abortion  6 (13.9)  3 (7.1)  0.308
Threat of  early  birth 4  (9.3) 6  (14.2)  0.477
Infections 10  (23) 2  (4.7) <0.05
Pre-eclampsia 3  (6.9) 0  (–) 0.080
Gestetional  diabetes  3 (6.9) 0 (–)  0.080
Chorioamnionitis 0 (–) 1 (2.3)  0.307
Antepartum hemorrhage 7  (16.2)  6 (14.2)  0.975
Other 2 (4.6) 2 (4.7)  0.975
Premature rupture  of  membranes
18--24 hrs  5 (11.6)  5 (11.9)  0.970
25--48 hrs  6 (13.9)  10  (23.8)  0.244
49--72 hrs  5 (11.6)  5 (11.9)  0.970
>72 hrs  11  (25.5)  17  (40.4)  0.143
Prenatal control
Yes  37  (86)  38  (90.4)  0.524
Table  2  Newborn  characteristics.
Neonatal  sepsis
n  =  43  (%)
Healthy
n  = 42  (%)
p
Weight  if  the  newborn  in grams
<1000  10  (23)  1 (2.3) <0.01
1000--1500 15  (65.2)  5 (11.9)  <0.05
1501--2500 11  (25.2)  21  (50)  <0.05
2501--4000 6  (13.9)  14  (33.3)  <0.05
>4000 1  (2.3)  1 (2.3) 0.981
Gestetional  age  in  weeks
<28 9  (20.9)  1 (2.3) <0.01
28--33 22  (51.1)  13  (30.9)  0.058
34--36 4  (9.3)  19  (45.2)  <0.001
37--42 8  (18.6)  9 (21.4)  0.744
Trophism
AGA 27  (62.7)  32  (76.1)  0.185
BGA 12  (27.9)  8 (19)  0.334
LGA 4  (9.3)  2 (4.7) 0.413
Gender 0.433
Male 23  (53.4)  26  (61.9)
Female 20  (46.5)  16  (38)
APGAR score  <0.05
0--3 0  (--) 0 (--)
4--6 10  (23.2)  2 (4.8)
7--10 33  (76.8)  40  (95.2)
AGA, adequate to gestational age; BGA, below gestational age; LGA, larger than gestational age.
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Table  3  Odds  ratio  (OR)  for  neonatal  sepsis  of  statistically  significant  value.
p  RM  IC  95%
Risk  factors
Maternal  infection  <0.001  19.5  3.99--95
Weight <1500  g <0.001  8.3  2.36--30
Gestational  age <28
weeks
<0.05  10.8  1.30--29
APGAR <6  at  5 min <0.05 6  1.22--29
Protective factors
Gestational  age
34--36 weeka
<0.01  0.12  0.037--0.409
Healthy colorb <0.01  0.25  0.034--1.89
a Protection factor or 8 to not  get sick.
b Protection factor of 4 to not get sick.
Table  4  Chorioamnionitis  with  sepsis  and  PRM  relation  >24  h.
Sensitivity  (%)  Specificity  (%)  PPV  (%)  NPV  (%)
Chorioamnionitis  and  neonatal  sepsis  51  35  44  41
Chorioamnionitis  and  ruptured  sac  >24 h  81  31  45  71
PRM, premature rupture of  membranes; PPV, positive predictive value; NPV, negative predictive value.
respectively),  a  non-significant  number.  Male  patients  were
53.4%  of  the neonates  within  the  sepsis  group  and  61.9%  of
the  healthy  group  (NS).  Regarding  the APGAR  score,  there
were  more  <6  scores  in the sepsis  group  (p  < 0.05)  (Table  2).
The  odds-ratio  (OR) analysis,  with  a confidence  level of
95%,  considering  risk  factors  for  neonatal  sepsis  develop-
ment  present  the following:  presence  of  maternal  infection
OR  =  19.5,  weight  at  birth  <1500  g OR  = 8.3, for the  gesta-
tional  age  <28  week  group  OR  =  10.8  and APGAR  <6  at 5  min
OR  =  6.  Protective  factors  to  avoid  getting  sick  are:  gesta-
tional  age  of  34--36  weeks  OR  = 0.12,  which establishes  a
protective  factor  of  8  and  the  corresponding  variable  of
a  healthy  mother  OR  =  0.25  with  a  protective  factor  of  4
(Table  3).
When  correlating  histological  chorioamnionitis  with  sep-
sis,  we  were  able  to  find  a  sensitivity  of  51%  and when
relating  chorioamnionitis  and  ruptured  sac  >24 h  we  were
able  to  find  a  sensitivity  of  81%  with  a specificity  of  31%,  a
positive  predictive  value  of  45%  and  a negative  predictive
value  of  71%  (Table 4).
Discussion
Chorioamnionitis  (or  intra-amniotic  infection)  refers  to the
inflammation  of  the amniochorionic  membrane  (in  chorion
and  amnion).  It  is  estimated  to  be  present  in approximately
2--4%  of  full-term  pregnancies,1,2 and in  approximately
40--70%  of  women  with  premature  deliveries.3,4 CAM  can
be  defined  clinically  based  on  maternal  symptoms,  includ-
ing  fever,  abdominal  pain,  abnormal  vaginal  flow  and
leukocytosis,5--7 as  well  as  histologically,  with  evidence  of
inflammation  and  necrosis  in the  entire chorionic  plate  and
amnion.1,8
Chorioamnionitis  is  linked  to  significant  morbidity  and
mortality  maternal  and  neonatal  rates.9 Neonatal  morbidi-
ties  include  a greater  risk  of  neonatal  sepsis,10 pneumonia,11
and  neurological  damage.12,13 On the other  hand,  chorioam-
nionitis  can  lead  to  fetal  inflammatory  response  syndrome,
which  brings  along  greater  risks  of  periventricular  leuko-
malacia,  cerebral  palsy14,15,34 and  chronic  pulmonary
disease.16,17
The  more  premature  the child  is, the greater  the  prob-
ability  of detecting  histological  chorioamnionitis.  A study
found  that  out  of those  cases  which  gave  birth between  21
and  24  weeks,  67%  showed  evidence  of  infection  and  histo-
logical  inflammation,  compared  to  22%  of those  who  gave
birth  between  weeks  33  and  36.18 In  our  study,  out  of  a
sample  of  85  patients,  58%  had  histologic  chorioamnionitis
(HCAM)  and  of the  septic  51%  CAMH.
Chorioamnionitis  occurs  more  frequently  as  a  result  of
ascending  vaginal  and cervix  bacteria,  it is  more  frequently
observed  as  a secondary  complication  to  a  prolonged  rup-
ture  of membranes.19 Less  common  ways of  infection  include
hematogenous  dissemination  or  transmission  posterior  to  an
invasive  procedure  (in  other  words,  amniocentesis,  chori-
onic villus  sampling,  or  other  fetal  procedure).  Bacterial,
viral  and in rare  occasions  fungal  agents  have been  related  to
the  pathogenesis  of  chorioamnionitis  and  premature  deliv-
ery.  Some  of  the commonly  identified  pathogens  include
Ureaplasma  urealyticum, Chlamydia  trachomatis, Neisseria
gonorrea, Mycoplasma  hominis,  group  B  strephtococcus  and
Trichomonas  vaginalis.  Additional  bacteria  include  gram-
negative  anaerobes,  including  Gardnerella  vaginalis  and
Bacteroides  spp.20--22
Fungal  organisms,  including  several  Candida  species
(Candida  albicans, Candida  tropicalis  and  Candida
glabrata),  have also  been associated  with  chorioamnionitis.
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These  infections  have  been reported  in pregnant  women
with  in  vitro  fertilization,  in  those  with  retained  intrauterine
devices  after  amniocentesis  and  in those  with  a prolonged
rupture  of  membranes.23--27 Organisms  like  Mycoplasma
are  typically  low  virulence organisms,  which explains  why
women  with  histological  chorioamnionitis  frequently  do  not
present  clinical  symptoms.27
Aside  from  colonization  with  bacteria  and  virus,  there  are
several  risk  factors  for the development  of  chorioamnionitis.
As  previously  discussed,  prematurity  and premature  rupture
of  membranes  are commonly  linked  to  chorioamnionitis.  In
our  casuistry,  86.5%  of  children  with  neonatal  sepsis  had  a
ruptured  sac of  over  24  h.  In  full-term  babies,  risk  factors
included:  long  duration  of delivery  and  of  the rupture  of
the  membrane,  and  nulliparity.28 Additionally,  women  with
early  rupture  of  membranes  at term  who  receive  multi-
ple  digital  vaginal  tests,  having  a prolonged  labor  or  with
meconium-stained  liquid  have  a greater  risk  of  developing
chorioamnionitis.29 In our  study,  we  were able  to  find  that
81%  of  children  who  had  ruptured  sac of  over  24  h and  pla-
centa  chorioamnionitis  had  neonatal  sepsis.
CAM  can  be  diagnosed  with  the  use  of  histological  or
clinical  criteria.  Clinical  diagnosis  is  based  in local  or  sys-
temic  infection  signs  and symptoms.  Common  definition
includes  maternal  fever  (fever>37,  5--38 ◦C)  and  one  of
the  following:  abdominal  pain,  uterine  pain,  fetid  vagi-
nal  flow,  maternal  tachycardia  (>100 heartbeats/min),  fetal
tachycardia  (persistent  elevation  of  fetal  cardiac  frequency
>160  heartbeats/min)  and  an  elevated  count  of  maternal
white  blood  cells  (>15,000  cells/mm3).  The  cut-off  point  for
maternal  fever  varies  through  several  studies.  However,  the
most  recent  literature  cites  a value  of  >38 ◦C,  thus  excluding
the  many  women  with  a low  degree  fever  during  delivery,
which  is  not  related  to  an  infectious  process.6,30,31
Chorioamnionitis  can occur  histologically,  and  is  orga-
nized  on  the  base  of  specific  criteria,  with  the increase
in  neutrophils  infiltration  and  the  development  of  necrosis,
thickening  of the amnion  basement  membrane  and chori-
onic  micro-abscesses  which are  seen  with  the increase  of
the  severity  of the disease.  Moreover,  fetal  inflammatory
response  can  progress  from  a  chorionic  vasculitis/umbilical
(infiltration  of  neutrophils  into  chorionic  or  umbilical  ves-
sels)  to necrotizing  funisitis  (inflammation  of  the umbilical
cords  conjunctive  tissue).8,13 Clinical  diagnosis  of chorioam-
nionitis,  however,  is  not always  confirmed  by  histological
or microbiological  studies.  In a  study  of  139 pregnancies
with  clinical  findings  of  chorioamnionitis,  the histological
exam  of the  placenta  did not  support  the clinical  diagnosis
in  approximately  a third  of  the cases.32 In  our  study,  49%
of  children  with  sepsis  had  a  histologically  normal  placenta.
Chorioamnionitis,  defined  by  positive  cultures  of  amniotic
liquid,  was  found  in  36%  of  women  with  premature  rupture
of  membranes.33
Conclusions
51%  of  newborns  with  histologic  chorioamnionitis  had sepsis.
Placenta  chorioamnionitis  with  premature  rupture  of  mem-
branes  of  more  than  24  h  has  an 81%  sensitivity  for  a neonatal
sepsis  diagnosis.
Limitations  of the  study
• A larger population  is  required  for  the findings  in our sam-
ples  to be real  for  the  general  population.
• In this  sample,  it was not possible  to  perform  a ROC  curve,
which  could  have been  helpful.
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